Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
BMJ Open, 2024Quantitative sensory testing and chronic pain syndromes: a cross-sectional study from TwinsUK
Rhee A., Granville Smith I., Compte R. et al.
Olink Target 96
Journal of Hazardous Materials, 2024Perinatal exposure to PBEB aggravates liver injury via macrophage-derived TWEAK in male adult offspring mice under western diet
Wang W., Shi X., Feng J. et al.
Journal of Proteome Research, 2024Olink Proteomics for the Identification of Biomarkers for Early Diagnosis of Postmenopausal Osteoporosis
Li C., Zang X., Liu H. et al.
Journal of Proteome Research, 2024Plasma Inflammation Markers Linked to Complications and Outcomes after Spontaneous Intracerebral Hemorrhage
Cheng X., Hu D., Wang C. et al.
BMC Psychiatry, 2024Exploring the relationship between lipid metabolism and cognition in individuals living with stable-phase Schizophrenia: a small cross-sectional study using Olink proteomics analysis
Zheng Y., Cai X., Wang D. et al.
Cell Reports Medicine, 2024Clinical-transcriptional prioritization of the circulating proteome in human heart failure
Perry A., Amancherla K., Huang X. et al.
Olink Explore 3072/384
ESC Heart Failure, 2024Elevated carbohydrate antigen 125 (CA125) is associated with incident heart failure and mortality in acute coronary syndrome
Yndigegn T., Gu T., Grufman H. et al.
Journal of the American College of Cardiology, 2024Reaffirmation of Mechanistic Proteomic Signatures Accompanying SGLT2 Inhibition in Patients With Heart Failure
Packer M., Ferreira J., Butler J. et al.
Immunity, 2024Meningeal lymphatic function promotes oligodendrocyte survival and brain myelination
das Neves S., Delivanoglou N., Ren Y. et al.
Olink Target 48 Mouse
npj Cardiovascular Health, 2024Using proteomics to identify the mechanisms underlying the benefits of statins on ischemic heart disease
Zhao J., Zhang J.
European Journal of Heart Failure, 2024Inhibition of myeloperoxidase to treat left ventricular dysfunction in non‐ischaemic cardiomyopathy
Geissen S., Braumann S., Adler J. et al.
Nature Cancer, 2024A targetable type III immune response with increase of IL-17A expressing CD4+ T cells is associated with immunotherapy-induced toxicity in melanoma
Dimitriou F., Cheng P., Saltari A. et al.
Journal of Affective Disorders, 2024Multi-omics combined to investigate potential druggable therapeutic targets for stroke: A systematic Mendelian randomization study and transcriptome verification
Shi Y., Bao L., Li Y. et al.
Scientific Reports, 2024Plasma proteomics and lipidomics facilitate elucidation of the link between Alzheimer's disease development and vessel wall fragility
Tokuoka S., Hamano F., Kobayashi A. et al.
PLOS ONE, 2024Is there a causal relationship between resistin levels and bone mineral density, fracture occurrence? A mendelian randomization study
Xu T., Li C., Liao Y. et al.
Journal of Experimental Medicine, 2024Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer
Tsimberidou A., Alayli F., Okrah K. et al.
European Journal of Heart Failure, 2024Association of ventricular–arterial coupling with biomarkers involved in heart failure pathophysiology – the STANISLAS cohort
Holm H., Magnusson M., Jujić A. et al.
Schizophrenia, 2024Elevated plasma matrix metalloproteinase 9 in schizophrenia patients associated with poor antipsychotic treatment response and white matter density deficits
Li X., Wang X., Yang Y. et al.
Nature Neuroscience, 2024Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies
Pichet Binette A., Gaiteri C., Wennström M. et al.
Frontiers in Immunology, 2024An exploratory clinical study of β-glucan combined with camrelizumab and SOX chemotherapy as first-line treatment for advanced gastric adenocarcinoma
Chu Y., He X., Xue Y. et al.
3195 publications
Items per page
1101-1120 of 3195 publications